Results 141 to 150 of about 4,104 (188)

Medical management pathways for Cushing's disease in pituitary tumors centers of excellence (PTCOEs). [PDF]

Pituitary
Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P, Freda P, Gadelha M, Haberbosch L, Kaiser UB, Lamberts S, Laws E, Nachtigall LB, Popovic V, Schilbach K, Lely AJV, Wass JAH, Melmed S, Casanueva FF.   +18 more
europepmc   +1 more source

The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide

, 2016
W. Linda, Ismael Domínguez-Rosado, Renee L. Gennarelli, Peter B. Bach, Mithat Gönen, Michael I. D’Angelica, Ronald P. DeMatteo, T. Peter Kingham, Murray F. Brennan, William R. Jarnagin, Peter J. Allen   +10 more
openalex   +1 more source

Clinical efficacy and safety of fluconazole treatment in patients with Cushing's syndrome. [PDF]

Ther Adv Endocrinol Metab
Liao TY, Lin YC, Huang CJ, Hwu CM, Lin LY.   +4 more
europepmc   +1 more source

Long-term antitumour effects of pasireotide in acromegaly

Romy van der Groef, Sophie E. M. Veldhuijzen van Zanten, Denise van Beekveld, Eskeatnaf Mulugeta, Julie Refardt, Sebastian Neggers   +5 more
openalex   +1 more source

Corrigendum: Estrogens modulate somatostatin receptors expression and synergize with the somatostatin analog pasireotide in prostate cells. [PDF]

Front Pharmacol
Rossi V, Di Zazzo E, Galasso G, De Rosa C, Abbondanza C, Sinisi AA, Altucci L, Migliaccio A, Castoria G.   +8 more
europepmc   +1 more source

Selective ligand recognition and activation of somatostatin receptors SSTR1 and SSTR3. [PDF]

Proc Natl Acad Sci U S A
Wang Y, Xu Y, Wang Y, Zhang J, Chen L, He X, Fan W, Wu K, Hu W, Cheng X, Yang G, Xu HE, Zhuang Y, Sun S.   +13 more
europepmc   +1 more source

The paradoxical GH response at OGTT does not predict Pasireotide efficacy but matters for glucose metabolism. [PDF]

J Endocrinol Invest
Occhi G, Voltan G, Chiloiro S, Bianchi A, Maffei P, Dassie F, Mantovani G, Del Sindaco G, Ferone D, Gatto F, Losa M, Cannavò S, Scaroni C, Ceccato F, Pituitary Club of the Italian Society of Endocrinology.   +14 more
europepmc   +1 more source

Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningiomain vitro

, 2017
Thomas Graillon, David Romano, Céline Defilles, Christophe Lisbonis, Alexandru Saveanu, Dominique Figarella‐Branger, Pièrre-Hugues Roche, S. Fuentès, Olivier Chinot, Henry Dufour, Anne Barlier   +10 more
openalex   +2 more sources

Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma in vitro

, 2017
Thomas Graillon, David Romano, Céline Defilles, Christophe Lisbonis, Alexandru Saveanu, Dominique Figarella‐Branger, Pièrre-Hugues Roche, S. Fuentès, Olivier Chinot, Henry Dufour, Anne Barlier   +10 more
openalex   +1 more source

Adherence, duration and healthcare costs in a real-world population of patients with acromegaly. [PDF]

J Comp Eff Res
Quock TP, Chang E, Das AK, Speller A, Tarbox MH, Rattana SK, Paulson IE, Broder MS.   +7 more
europepmc   +1 more source